2型糖尿病预防的热门方式
本文综述了糖尿病前期的流行病学负担及2型糖尿病(T2D)预防策略的研究进展。预防策略包括强化生活方式干预和多种改善胰岛素抵抗的药物;肠道微生物组研究提示粪菌移植可能具有预防作用;多种肠促胰岛素类药物在T2D预防和治疗中显示出前景。
要点
- T2D预防策略以强化生活方式干预和改善胰岛素抵抗的药物为主。
- 肠道微生物组在糖尿病进展中的作用受到关注,粪菌移植可能具有预防作用。
- 多种肠促胰岛素类药物在T2D预防和治疗中显示出前景。
核心结论
- T2D的新型预防方式正在快速增加,照护糖尿病个体者需全面理解这些新疗法的适应证、结局与局限性。
研究设计与样本
- 本文为综述,检索PubMed与Ovid MEDLINE数据库中关于糖尿病前期及T2D预防的近期系统综述、Meta分析和原创研究文章。
主要发现
- T2D预防策略集中于强化生活方式干预以及多种最终改善胰岛素抵抗的药物。
- 近期对肠道微生物组在糖尿病进展中作用的更好理解,提示粪菌移植可能具有预防作用。
- 多种肠促胰岛素类药物已被开发,在T2D的预防和治疗中显示出前景。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Prediabetes now affects a substantial proportion of the population, marking a growing group of individuals at increased risk for the development of type 2 diabetes (T2D). Given the profound effect of T2D on an individual's morbidity and mortality, T2D prevention is of critical importance. EVIDENCE ACQUISITION: We searched PubMed and Ovid MEDLINE databases for recent systematic reviews, meta-analyses, and original research articles pertaining to prediabetes and the prevention of T2D. EVIDENCE SYNTHESIS: T2D prevention strategies have focused on intensive lifestyle modification as well as numerous medications that ultimately improve insulin resistance. Recently, a better understanding of the gut microbiome's role in diabetes progression has suggested a possible preventive role for fecal transplant. Finally, multiple incretin pharmaceutical agents have been developed that show promise in the prevention and treatment of T2D. CONCLUSION: The number of novel ways to prevent T2D is rapidly growing. A thorough understanding of the indications, outcomes, and limitations of these new therapies is critical for all who care for individuals with diabetes.
引用
- Lundgrin EL, Hatipoglu B. Trending Modalities in Type 2 Diabetes Prevention. J Clin Endocrinol Metab. 2025. PMID: 39998920. doi:10.1210/clinem/dgaf040
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。